Evidence map›Paper›PMID 29181270›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2017

Safety and accuracy of

Chenue Abongwa, Sarah Mott, Blanca Schafer, Parren McNeely, Ghada Abusin, Thomas O'Dorisio, Gideon Zamba, M Sue O'Dorisio, Yusuf Menda

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01619865 (Safety & Efficacy of 68Ga-DOTA-tyr3-Octreotide PET/CT in Diagnosis, Staging & Measurement of Response to Treatment in Patients With Somatostatin Receptor Positive Tumors), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01619865 phase1 / phase2completednot on this map

Safety & Efficacy of 68Ga-DOTA-tyr3-Octreotide PET/CT in Diagnosis, Staging & Measurement of Response to Treatment in Patients With Somatostatin Receptor Positive Tumors: Comparison to Octreoscan Plus High-Resolution, Contrast Enhanced CT.

TypeinterventionalSponsorSue O'DorisioRan2012 to 2017Enrolled223ConditionsNeuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma, MedulloblastomaArms68Ga-DOTATOC PET/CT
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. The University of Iowa Neuroendocrine Tumor Clinic.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Chenue AbongwaDepartment of Pediatrics, Roy J. and Lucille A. Carver College of Medicine, University of IowaIowa City, Iowa 52242, USA.
Sarah MottHolden Comprehensive Cancer Center, Roy J. and Lucille A. Carver College of Medicine, University of IowaIowa City, Iowa 52242, USA.
Blanca SchaferDepartment of Pediatrics, Roy J. and Lucille A. Carver College of Medicine, University of IowaIowa City, Iowa 52242, USA.
Parren McNeelyDepartment of Radiology, Roy J. and Lucille A. Carver College of Medicine, University of IowaIowa City, Iowa 52242, USA.
Ghada AbusinDepartment of Pediatrics, Roy J. and Lucille A. Carver College of Medicine, University of IowaIowa City, Iowa 52242, USA.
Thomas O'DorisioDepartment of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of IowaIowa City, Iowa 52242, USA.
Gideon ZambaDepartment of Biostatistics, College of Public Health, University of IowaIowa City, Iowa 52242, USA.
M Sue O'DorisioDepartment of Pediatrics, Roy J. and Lucille A. Carver College of Medicine, University of IowaIowa City, Iowa 52242, USA.
Yusuf MendaDepartment of Radiology, Roy J. and Lucille A. Carver College of Medicine, University of IowaIowa City, Iowa 52242, USA.
University of Iowa · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
Project 4: New Approaches to Improving the Effectiveness of Radionuclide Targeted Treatments in Neuroendocrine TumorsP50CA174521 · NCI · UNIVERSITY OF IOWA · PI ODORISIO, THOMAS · 2015 to 2021
$13.2M
Image-guided Diagnosis and Therapy of Neuroendocrine TumorsR01CA167632 · NCI · UNIVERSITY OF IOWA · PI MENDA, YUSUF, O'DORISIO, M. SUE · 2012 to 2016
$2.6M
National Research Service Award Institutional Research Training Grants (T32)T32HL080070 · NHLBI · UNIVERSITY OF IOWA · PI O'DORISIO, M. SUE · 2005 to 2014
$1.5M
DOSIMETRY IN CHILDREN AND YOUNG ADULTS WITH NEUROBLASTOMA OR NEUROENDOCRINE TUMORR21CA134198 · NCI · UNIVERSITY OF IOWA · PI BUSHNELL, DAVID L, O'DORISIO, M. SUE · 2008 to 2009
$615k
NCI NIH HHS P50 CA174521NCI NIH HHS R01 CA167632
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

68Ga-DOTATOCchildrensolid tumorsomatostatin

Identifiers

PMID29181270
PMCPMC5698616
OpenAlexW3000500372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.